Provided by Tiger Trade Technology Pte. Ltd.

Hoth Therapeutics

0.9234
-0.0666-6.73%
Post-market: 0.94000.0166+1.80%19:55 EDT
Volume:517.22K
Turnover:494.72K
Market Cap:14.33M
PE:-0.91
High:1.00
Open:0.9779
Low:0.9200
Close:0.9900
52wk High:2.12
52wk Low:0.6554
Shares:15.51M
Float Shares:14.96M
Volume Ratio:0.92
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0134
EPS(LYR):-1.2844
ROE:-151.13%
ROA:-84.46%
PB:1.74
PE(LYR):-0.72

Loading ...

Hoth Therapeutics Inc Files for Mixed Shelf Offering of Upto $50 Mln - SEC Filing

THOMSON REUTERS
·
Nov 17, 2025

Hoth Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

BRIEF-Hoth Therapeutics Launches VA-Backed Study Of Novel GDNF Weight Loss Therapy Targeting Obesity And Fatty Liver Disease

Reuters
·
Oct 27, 2025

Hoth Therapeutics Launches Va-Backed Study of Novel Gdnf Weight Loss Therapy Targeting Obesity and Fatty Liver Disease

THOMSON REUTERS
·
Oct 27, 2025

Hoth Therapeutics Inc - Initial Results Expected Q1 2026

THOMSON REUTERS
·
Oct 27, 2025

Hoth Therapeutics Shares Rise 6.3% After FDA's Orphan Drug Tag for Rare Tumor Drug

THOMSON REUTERS
·
Oct 21, 2025

BUZZ-Hoth Therapeutics rises after FDA's orphan drug tag for rare tumor drug

Reuters
·
Oct 21, 2025

BRIEF-Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers

Reuters
·
Oct 21, 2025

Hoth Therapeutics Secures Japan Patent for HT-KIT, Extending Protection Through 2039

Reuters
·
Oct 21, 2025

Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for Ht-Kit in Rare C-Kit-Driven Cancers

THOMSON REUTERS
·
Oct 21, 2025

Hoth Therapeutics Prepares Presentation on October 17, 2025

TIPRANKS
·
Oct 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, First Majestic, Best Buy

Reuters
·
Oct 09, 2025

Hoth Therapeutics Shares up 5.8% After Co Partners With Nvidia for AI Powered Drug Research

THOMSON REUTERS
·
Oct 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Ford Motor, CVS Health, Phillips 66

Reuters
·
Oct 08, 2025

BUZZ-Hoth Therapeutics rises as it expands AI push with Nvidia licenses

Reuters
·
Oct 08, 2025

BRIEF-Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform

Reuters
·
Oct 08, 2025

Hoth Therapeutics CEO to Present Advancements in Oncology Pipeline at BIO-Europe Conference in Vienna

Reuters
·
Oct 07, 2025

Hoth Therapeutics expands intellectual property portfolio for HT-001

TIPRANKS
·
Sep 24, 2025

Hoth Therapeutics Announces Expansion of HT-001 Patent Portfolio Targeting Skin Toxicities from Cancer Therapies

Reuters
·
Sep 24, 2025

Hoth Therapeutics Expands Ht-001 Development With Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and Menin Inhibitor-Associated Skin Toxicities

THOMSON REUTERS
·
Sep 24, 2025